Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axogen, Inc. | EVP and General Counsel | Performance Stock Units | 68.6K | $515K | $7.50 | Feb 22, 2024 | Direct |
ABIOMED INC | VP & GENERAL COUNSEL | Common Stock, $0.01 par value | 0 | $373.99 | Dec 22, 2022 | Direct | |
ABIOMED INC | VP & GENERAL COUNSEL | Perf ormance Stock Units | 0 | Dec 22, 2022 | Direct | ||
ABIOMED INC | VP & GENERAL COUNSEL | Stock Option (Right to Buy) | 0 | Dec 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXGN | Axogen, Inc. | Feb 22, 2024 | 1 | $0 | 4 | Feb 23, 2024 | EVP and General Counsel |
AXGN | Axogen, Inc. | Mar 20, 2023 | 0 | $0 | 3 | Mar 30, 2023 | EVP & General Counsel |
NASD | ABIOMED INC | Dec 22, 2022 | 6 | $0 | 4 | Dec 27, 2022 | VP & GENERAL COUNSEL |
NASD | ABIOMED INC | Nov 4, 2022 | 2 | -$1.33M | 4 | Nov 8, 2022 | VP & GENERAL COUNSEL |
NASD | ABIOMED INC | Aug 29, 2022 | 1 | -$128K | 4 | Aug 30, 2022 | VP & GENERAL COUNSEL |
NASD | ABIOMED INC | May 26, 2022 | 4 | -$388K | 4 | May 31, 2022 | VP & GENERAL COUNSEL |
NASD | ABIOMED INC | May 25, 2022 | 1 | -$74.3K | 4 | May 27, 2022 | VP & GENERAL COUNSEL |
ABMD | ABIOMED INC | Nov 6, 2021 | 1 | -$55K | 4 | Nov 9, 2021 | VP & General Counsel |
ABMD | ABIOMED INC | Nov 3, 2021 | 2 | -$542K | 4 | Nov 5, 2021 | VP & General Counsel |
ABMD | ABIOMED INC | Jul 23, 2021 | 1 | -$34.3K | 4 | Jul 26, 2021 | VP & General Counsel |
ABMD | ABIOMED INC | May 29, 2021 | 1 | -$137K | 4 | Jun 2, 2021 | VP & General Counsel |
ABMD | ABIOMED INC | May 25, 2021 | 2 | $0 | 4 | May 27, 2021 | VP & General Counsel |